Late onset haemolysis and red cell autoimmunisation after allogeneic bone marrow transplant

被引:80
|
作者
Chen, FE
Owen, I
Savage, D
Roberts, I
Apperley, J
Goldman, JM
Laffan, M
机构
[1] ROYAL POSTGRAD MED SCH,DEPT HAEMATOL,LONDON W12 0HS,ENGLAND
[2] ROYAL POSTGRAD MED SCH,LRF ADULT LEUKAEMIA UNIT,LONDON W12 0HS,ENGLAND
关键词
bone marrow transplantation; haemolysis; autoimmune; antibody;
D O I
10.1038/sj.bmt.1700677
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
We reviewed the medical records of 293 patients who underwent allogeneic bone marrow transplants at the Hammersmith Hospital between 1989 and 1994, There was clinical evidence of an autoimmune reaction against red cells in nine patients. Seven of these patients had significant haemolysis; the other two had red cell autoagglutination, Haemolysis was resistant to treatment in three cases, Six of the nine patients had monoclonal Ig bands identified within 1 year of transplant, The autoimmune reaction could be classified broadly into two types: an early onset type (II = 4) beginning 2 to 8 months post-transplant associated with a cold antibody, and a late onset type (n = 5) beginning 6 to 18 months post-transplant associated with warm antibodies, The predominant antibody in the two categories described may reflect the kinetics of immune reconstitution posttransplant, since serum IgM levels typically return to normal 2 to 6 months post-transplant, while IgG levels may not reach normal levels until 12-18 months post-transplant, We speculate that unbalanced reconstitution of B and T cell lymphopoiesis post-transplant may favour emergence of oligoclonal proliferation and that some of the resulting antibodies may have activity against red cells.
引用
收藏
页码:491 / 495
页数:5
相关论文
共 50 条
  • [1] Late onset haemolysis and red cell autoimmunisation after allogeneic bone marrow transplant
    FE Chen
    I Owen
    D Savage
    I Roberts
    J Apperley
    JM Goldman
    M Laffan
    [J]. Bone Marrow Transplantation, 1997, 19 : 491 - 495
  • [2] Late onset bone marrow transplant nephropathy
    Oyama, Y
    Komatsuda, A
    Imai, H
    Ohtani, H
    Hamai, K
    Wakui, H
    Miura, AB
    Nakamoto, Y
    [J]. INTERNAL MEDICINE, 1996, 35 (06) : 489 - 493
  • [3] Late-onset cerebral toxoplasmosis after allogeneic bone marrow transplantation
    A Tefferi
    BP O’Neill
    DJ Inwards
    [J]. Bone Marrow Transplantation, 1998, 21 : 1285 - 1286
  • [4] Late-onset cerebral toxoplasmosis after allogeneic bone marrow transplantation
    Tefferi, A
    O'Neill, BP
    Inwards, DJ
    [J]. BONE MARROW TRANSPLANTATION, 1998, 21 (12) : 1285 - 1286
  • [5] Life after allogeneic bone marrow transplant
    Hockings, Catherine
    Peggs, Karl
    [J]. BRITISH JOURNAL OF HOSPITAL MEDICINE, 2012, 73 (06) : C93 - C96
  • [6] Late-onset noninfectious pulmonary complications after allogeneic bone marrow transplantation
    Palmas, A
    Tefferi, A
    Myers, TL
    Scott, JP
    Swensen, SJ
    Chen, MG
    Gastineau, DA
    Gertz, MA
    Inwards, DJ
    Lacy, MQ
    Litzow, MR
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1998, 100 (04) : 680 - 687
  • [7] Recombinant erythropoietin to reduce red blood cell transfusions in late anemia after allogeneic bone marrow transplantation
    Renges, H
    Kröger, N
    Krüger, W
    Wasilewski, F
    Zander, AR
    [J]. BONE MARROW TRANSPLANTATION, 2001, 27 : S162 - S162
  • [8] Recombinant human erythropoietin for late-onset anemia after allogeneic bone marrow transplantation
    Fujimori, Y
    Kanamaru, A
    Saheki, K
    Mori, A
    Takatsuka, H
    Wada, H
    Okada, M
    Tamura, S
    Okamoto, T
    Takemoto, Y
    Kakishita, E
    Nagai, K
    [J]. INTERNATIONAL JOURNAL OF HEMATOLOGY, 1998, 67 (02) : 131 - 136
  • [9] Late onset Epstein–Barr virus-associated lymphoproliferative disease after allogeneic bone marrow transplant presenting as breast masses
    SH Abhyankar
    K-Y Chiang
    JP McGuirk
    AR Pati
    KT Godder
    JA Welsh
    RL Waldron
    JL McElveen
    PJ Henslee-Downey
    [J]. Bone Marrow Transplantation, 1998, 21 : 295 - 297
  • [10] Second allogeneic bone marrow transplant after relapse of hematologic malignancies following first autologous or allogeneic bone marrow transplant.
    Roberts, T
    Koc, Y
    Sprague, K
    Grodman, H
    Mogavero, D
    Berkman, E
    Schenkein, D
    Miller, KB
    [J]. BLOOD, 1999, 94 (10) : 380B - 380B